Cell Viability is a critical parameter that assesses the overall health and functionality of cells within a biological system. It represents the ability of cells to maintain their structural and functional integrity, reflecting their capacity to survive and carry out essential physiological processes. Viability assays are employed to evaluate the number of live and dead cells in a population, providing valuable information for various research fields, including cell biology, drug discovery, and toxicology. Common viability assays measure cellular parameters such as membrane integrity, metabolic activity, and mitochondrial function. Cell viability is essential in understanding the impact of experimental conditions, treatments, or environmental factors on cellular health. Techniques like trypan blue exclusion, MTT assay, and propidium iodide staining are widely used to assess viability by distinguishing between live and dead cells. Maintaining cell viability is crucial for experimental reproducibility and ensuring the reliability of cellular models. Viability considerations are particularly significant in fields like tissue engineering and regenerative medicine, where the survival of transplanted cells is critical for therapeutic success. Monitoring cell viability is also crucial in medical diagnostics and in evaluating the effectiveness of anticancer treatments. The assessment of viability aids in identifying apoptotic or necrotic cell death pathways, offering insights into the cellular responses to various stimuli. Overall, understanding and maintaining cell viability are fundamental aspects of cellular biology, influencing experimental outcomes and advancing our comprehension of cellular behavior in health and disease.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States